Agency
The disclosure standard for this register, and the only company that builds a drug holiday into its own billing — hydroquinone cycled off automatically, the right bottle sent without being asked. What it still will not publish is a concentration range.
MODEL
Dermatology provider consultation, personalised compounded formula, 60-day supply on subscription. A Curology brand.
The brand verdict
Two products assessed, and on every axis except one this is the best-run operation in the register. Both publish a full inactive ingredient list. Both describe their side effects. Both state the sample size and duration on their own survey claims and call them surveys rather than dressing a self-report as a clinical result. One carries a pregnancy warning on a retinoid page — the first we found anywhere. The other publishes a fill weight, which no other product in sixteen reviews does.
The standout is structural rather than pharmacological. Agency cycles hydroquinone off automatically: two to three months on, then two months on a hydroquinone-free formula that keeps treating pigment, with the company switching the bottle so the patient never has to track it. We have criticised six products across two other companies for selling time-limited courses through subscriptions that default to continuation. This is the only company that has built the stop into the billing, and it is designing against its own short-term commercial interest to do it.
The consistent gap is concentrations. Both products are personalised, which is a legitimate reason not to print a single figure on a page — and not a reason to withhold a range. For the retinoid that means a buyer cannot tell whether they are getting 0.015% or 0.1%; for hydroquinone it means they cannot weigh their own exposure against the threshold the ochronosis literature keys on.
There is one specific omission worth fixing rather than generalising about: the Dark Spot Formula contains hydrocortisone according to the company's own support material, and the product page does not name it. A topical corticosteroid should appear on the page that sells it.
- The only company here that cycles hydroquinone off automatically, and ships the right bottle without being asked.
- Among the only products in this register to publish full inactive ingredient lists — the other is Curology's DayPrimeRx, from the same parent company.
- The only published fill weight in sixteen reviews, which finally makes cost per application computable.
- Publishes an antioxidant system — ascorbic acid, sodium bisulfite, BHT — appropriate to a hydroquinone preparation, in the ingredient list where it can be checked.
- Discloses which formula variants contain propylene glycol, and that tretinoin versions contain BHT.
- The only retinoid page here carrying a pregnancy warning.
- Describes the adjustment period instead of promising results by day 30.
- Gives a real titration instruction: start every other night, build to nightly.
- States sample size and duration on its own survey claim, and calls it a survey.
- Publishes supply duration, so the monthly price can actually be reasoned about.
The range
- R-162026-07-25
Dark Spot Formula
PERSONALISED · CYCLEDThe subscription cycles the hydroquinone off for you — two to three months on, then two months on a hydroquinone-free formula, switched automatically. After sixteen reviews of courses sold as open-ended subscriptions, somebody finally built the break into the billing.
CONDITIONAL$35 PER MONTH
- R-172026-07-25
Eye Formula
PERSONALISEDAn anhydrous, preservative-light base for the thinnest skin on the body, and the most specific application instruction in this register — avoid your upper eyelids. It also claims to brighten dark circles with no pigment active in it.
CONDITIONAL$38 PER MONTH
- R-152026-07-25
Future Formula
PERSONALISED · BY CUROLOGYThe first product in this register to publish its inactive ingredients, disclose its side effects, and carry a pregnancy warning on a retinoid page. The concentrations are still not stated up front — but here, unusually, there is a defensible reason.
CONDITIONAL$40 PER MONTH
What repeats across the range
These are the findings a single review cannot make. Each one appears in more than one product, and each is drawn from the reviews above rather than from an impression of the brand.
- 01
The subscription enforces the drug holiday
Hydroquinone runs two to three months, then two months on a hydroquinone-free formula, switched automatically. Across sixteen reviews this is the only instance of a company making the clinically correct behaviour the default rather than leaving it to a prescriber conversation inside a billing arrangement that quietly renews. It also doubles as a steroid holiday, since the hydroquinone formula contains hydrocortisone.
- 02
Disclosure is the differentiator, not the pharmacology
The formulas are good but familiar in shape. What separates this company is that both products publish full inactive lists, flag irritants like propylene glycol, describe the adjustment period, carry a pregnancy warning on the retinoid, and publish a fill weight on the dark spot cream — the only fill weight in the register.
- 03
Personalisation is a real reason, and a partial excuse
Concentrations vary per patient, so no single figure can be printed. That is legitimate. It does not explain the absence of a published range, and for hydroquinone in particular the range is what the safety literature keys on. Third-party listings show the retinoid family running roughly 0.015% to 0.1%.
- 04
Grade C claims, presented honestly
85% on one product from 231 patients, 79% on the other from 147, both over nine to twelve months, both labelled surveys. Still uncontrolled self-reported preference data — but with n, duration and an accurate description attached, and over a window in which these drugs genuinely act. Competitors report comparable figures at day 30 for products their own pages say take months.
- 05
The best feature is in the wrong place
The hydroquinone cycling schedule is the strongest argument for buying from this company and it lives in a support article rather than on the product page. So does the fact that the formula contains a corticosteroid. Both belong where the purchase decision happens.
Disclosure scorecard
Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.
SCROLL THE TABLE SIDEWAYS
| PRODUCT | CONC. ON PAGE | CONC. FINDABLE | CONTRA-INDICATIONS | SIZE | SIDE EFFECTS |
|---|---|---|---|---|---|
| Dark Spot Formula | NO | PART | PART | YES | YES |
| Eye Formula | NO | NO | YES | YES | YES |
| Future Formula | NO | PART | YES | PART | YES |
If you buy one
Dark Spot Formula
Worth buying for a specific person with a specific problem. Read who.
Future Formula
Worth buying for a specific person with a specific problem. Read who.